While the pandemic has been the focus of R&D attention for much of 2020, that is slowly beginning to shift towards other projects in the big pharma pipeline ... for pharma companies to quietly ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with a substantial market capitalization of $110.13 billion, continues to ...
Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Innate Pharma (IPHA ... promising development pipeline and strategic initiatives. The company has shown progress ...
Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...
New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment ...
Back in 2017, the UK biotech RedX Pharma had to sell ... RedX CEO Lisa Anson said the company is back on its feet financially after a transformative year of pipeline progress and fundraising.
TipRanks on MSN2mon
Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development PipelineAthira Pharma, Inc. (ATHA) has disclosed a new risk ... as well as suspension or withdrawal of regulatory approvals. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback